Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant
Clinical trial NCT01122784 · COMPLETED
Trial details
- NCT number
- NCT01122784
- Sponsor
- DynPort Vaccine Company LLC, A GDIT Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2012-05-01
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.